Emerald Mutual Fund Advisers Trust Sells 2,753 Shares of Integer Holdings Corporation (NYSE:ITGR)

Emerald Mutual Fund Advisers Trust decreased its stake in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 13.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,114 shares of the medical equipment provider's stock after selling 2,753 shares during the quarter. Emerald Mutual Fund Advisers Trust's holdings in Integer were worth $2,020,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also bought and sold shares of ITGR. TD Private Client Wealth LLC boosted its holdings in Integer by 5.8% during the 1st quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider's stock worth $180,000 after acquiring an additional 83 shares during the last quarter. HighPoint Advisor Group LLC raised its stake in shares of Integer by 6.4% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider's stock worth $234,000 after purchasing an additional 101 shares during the period. Corient Private Wealth LLC raised its stake in shares of Integer by 6.4% during the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider's stock worth $261,000 after purchasing an additional 118 shares during the period. Xponance Inc. raised its stake in shares of Integer by 5.1% during the 1st quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock worth $297,000 after purchasing an additional 122 shares during the period. Finally, Bessemer Group Inc. raised its stake in shares of Integer by 73.1% during the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 125 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.

Insider Transactions at Integer

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the sale, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Donald J. Spence sold 14,739 shares of the company's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the transaction, the director directly owned 18,781 shares in the company, valued at approximately $2,260,856.78. The trade was a 43.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock valued at $44,577,115 in the last quarter. 2.16% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on ITGR shares. Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. KeyCorp lowered their target price on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Truist Financial set a $150.00 price objective on Integer and gave the company a "buy" rating in a research note on Friday, April 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and boosted their price objective for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Finally, Raymond James Financial boosted their price objective on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $145.00.

Integer Trading Down 1.7%

Shares of NYSE:ITGR traded down $2.02 during midday trading on Tuesday, hitting $117.45. 409,538 shares of the stock traded hands, compared to its average volume of 388,768. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78. Integer Holdings Corporation has a one year low of $104.93 and a one year high of $146.36. The business's 50 day moving average is $119.91 and its two-hundred day moving average is $124.82. The stock has a market capitalization of $4.10 billion, a PE ratio of 55.66, a P/E/G ratio of 1.03 and a beta of 0.98.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. During the same period last year, the company posted $1.14 EPS. Integer's revenue was up 7.3% on a year-over-year basis. As a group, research analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.